3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
21
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
7
Skin Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Uveal Melanoma
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pleural Effusion, Malignant
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
Specimen Handling
9
Nivolumab
9
Ipilimumab
7
cabozantinib
6
CTLA-4 Antigen
6
pembrolizumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
4
Axitinib
4
lenvatinib
2
fludarabine
2
Blood Specimen Collection
2
tivozanib
1
sodium-iodide symporter
1
sitravatinib
1
belzutifan
1
aldesleukin
1
Zoledronic Acid
1
Tissue Banks
1
Selenomethionine
1
Radiotherapy
1
Radiopharmaceuticals
1
Pluvicto
1
Nephrectomy
1
Metastasectomy
1
Inulin
1
Immunoglobulin G
1
Ibandronic Acid
1
Hyaluronoglucosaminidase
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Clear-cell metastatic renal cell carcinoma
×
Interleukin-2
×
1 year
×
Clear all
No trials found.